HORSE-RACING EFFECT AND CLINICAL TRIALS IN OLDER PERSONS

HORSE-RACING EFFECT AND CLINICAL TRIALS IN OLDER PERSONS

Bibliographic Details
Main Authors:	Matteo eCesari, Marco eCanevelli
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-07-01
Series:	Frontiers in Aging Neuroscience
Subjects:	Eligibility Determination Bias Elderly clinical trials clinical research methodology
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00175/full

Similar Items

Time to broaden the eligibility criteria in paediatric oncology trials? An analysis of patients with rhabdomyosarcoma non-eligible to the EpSSG RMS2005 trial
by: Gianni Bisogno, et al.
Published: (2023-01-01)

Investigating potential disparities in clinical trial eligibility and enrollment at an NCI‐designated comprehensive cancer center
by: Monica A. Patel, et al.
Published: (2023-06-01)

The effect of prior cancer on non‐small cell lung cancer trial eligibility
by: Michael Herman, et al.
Published: (2021-07-01)

What Is Ailing Oncology Clinical Trials? Can We Fix Them?
by: Abhenil Mittal, et al.
Published: (2024-06-01)

Clinical drug trials in general practice: how well are external validity issues reported?
by: Anja Maria Brænd, et al.
Published: (2017-12-01)

Eligible-and-enrolled vs. eligible-but-not-enrolled patients with chronic ischaemic heart failure in randomized clinical trials of myocardial regeneration
by: Łukasz Czyż, et al.
Published: (2022-11-01)

The problem of eligibility criteria in biomedical experiment: Philosophical and methodological analysis
by: Nartova, Maria Andreevna
Published: (2024-06-01)

Eligibility criteria in clinical trials in breast cancer: a cohort study
by: Katarzyna Szlezinger, et al.
Published: (2023-07-01)

Temporal trends and characteristics of clinical trials for which only one racial or ethnic group is eligible
by: Brian L. Egleston, et al.
Published: (2018-03-01)

Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer
by: Elizabeth J. Rowe, et al.
Published: (2022-12-01)

Semantic categorization of Chinese eligibility criteria in clinical trials using machine learning methods
by: Hui Zong, et al.
Published: (2021-04-01)

How Adequate is the Adequate Kidney Function for Clinical Trial Enrollment of Novel Anticancer Drugs?
by: Nehal Gamal, et al.
Published: (2020-12-01)

Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren’s syndrome: examination of data from the UK Primary Sjögren’s Syndrome Registry
by: Alexandre Dumusc, et al.
Published: (2018-02-01)

CriteriaMapper: establishing the automatic identification of clinical trial cohorts from electronic health records by matching normalized eligibility criteria and patient clinical characteristics
by: K. Lee, et al.
Published: (2024-10-01)

Eligibility of Asian and European registry patients for phase III trials in heart failure with reduced ejection fraction
by: Yvonne Mei Fong Lim, et al.
Published: (2024-12-01)

Potential Applications of Artificial Intelligence in Clinical Trials for Alzheimer’s Disease
by: Younghoon Seo, et al.
Published: (2022-02-01)

Brief Report: Real-World Eligibility for Clinical Trials in Patients With Extensive-Stage SCLC at a Tertiary Care Center
by: Navdeep Dehar, M.B.B.S., MD, MBT, FRCPC, et al.
Published: (2024-07-01)

Feasibility of Using Oncology-Specific Electronic Health Record (EHR) Data to Emulate Clinical Trial Eligibility Criteria
by: Thomas W. Wilson, et al.
Published: (2023-05-01)

Designing clinical trials
by: Smita Narayan
Published: (2021-01-01)

Analysis of eligibility criteria in Alzheimer’s and related dementias clinical trials
by: Alexandra K. Mitchell, et al.
Published: (2024-07-01)

Treatment eligibility in Alaska Native and American Indian persons with hepatitis C virus infection
by: Stephen E. Livingston, et al.
Published: (2012-04-01)

What is the purpose of clinical trial monitoring?
by: Sharon B. Love, et al.
Published: (2022-10-01)

Striking a match between FHIR‐based patient data and FHIR‐based eligibility criteria
by: Brian S. Alper, et al.
Published: (2023-10-01)

Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria
by: Muneer J. Al-Husseini, et al.
Published: (2019-08-01)

Automated classification of clinical trial eligibility criteria text based on ensemble learning and metric learning
by: Kun Zeng, et al.
Published: (2021-07-01)

Sociodemographic diversity in cancer clinical trials: New findings on the effect of race and ethnicity
by: Shelby Meyer, et al.
Published: (2021-03-01)

A comparative study of pre-trained language models for named entity recognition in clinical trial eligibility criteria from multiple corpora
by: Jianfu Li, et al.
Published: (2022-09-01)

The effect of a multicomponent exercise protocol (VIVIFRAIL©) on inflammatory profile and physical performance of older adults with different frailty status: study protocol for a randomized controlled trial
by: Marina Petrella, et al.
Published: (2021-01-01)

Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation
by: Diana N. Vikulova, et al.
Published: (2020-06-01)

Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study
by: Constance X. Zou, et al.
Published: (2018-10-01)

External validity of randomized clinical trial studying preventing depressive symptoms following acute coronary syndrome
by: Michael Tvilling Madsen, et al.
Published: (2021-08-01)

Barriers to non-small cell lung cancer trial eligibility
by: Jeffrey J. Hardesty, et al.
Published: (2018-03-01)

How implementation of systems biology into clinical trials accelerates understanding of diseases
by: Bibiana eBielekova, et al.
Published: (2014-06-01)

Eligibility of real-world patients with metastatic breast cancer for clinical trials
by: Atul Batra, et al.
Published: (2020-12-01)

Clinical trial reporting performance of thirty UK universities on ClinicalTrials.gov—evaluation of a new tracking tool for the US clinical trial registry
by: Sarai Mirjam Keestra, et al.
Published: (2021-06-01)

Outcome reporting bias in nephrology randomized clinical trials: Examining outcomes represented by graphical illustrations
by: Frank Ward, et al.
Published: (2022-08-01)

Clinical researchers’ insights on key data for eligibility screening in clinical studies
by: Betina Idnay, et al.
Published: (2024-01-01)

Use of durvalumab in stage III non‐small‐cell lung cancer based on eligibility for the PACIFIC study
by: Emma Boys, et al.
Published: (2023-02-01)

Publication of studies registered in Clinical Trials Registry of India: An audit of mood disorder research protocols from 2009-2019
by: Vikas Menon, et al.
Published: (2023-01-01)

randomizeR: An R Package for the Assessment and Implementation of Randomization in Clinical Trials
by: Diane Uschner, et al.
Published: (2018-06-01)